Twist Bioscience
Oxford Nanopore Technologies, Twist Bioscience Partner for Pharmacogenomics Beta Program
The program aims to integrate Twist’s NGS target enrichment technology with Oxford Nanopore’s sequencing platform to develop long-read PGx workflows.
In Brief This Week: Myriad Genetics, Diaceutics, Agios, Precipio, Lantern Pharma, Guardant Health
News items for the week of Jan. 18, 2021.
Twist Bioscience, Neogene Therapeutics Partner to Develop Personalized CAR T Cells, TCR Therapies
The companies will combine Neogene's expertise in targeting tumor neoantigens with Twist's DNA synthesis platform and product lines.